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▼The cloning of genomic or cDNA fragments by conven-
tional plaque hybridization (Ref. 1) has developed to be-
come an important tool in molecular biology, increasing
our understanding of biological phenomena. However, the
isolation of low-copy genes or simultaneous cloning of
a pair of different genes is still an expensive and time-
consuming procedure, often yielding false-positive recom-
binant clones. Since PCR-based screening methods have
been established, cloning has become more efficient but
often requires laborious subdivision and amplification of
library fractions, followed by the detection of recombinant
clones by Southern hybridization experiments (Ref. 2).
To avoid these problems we developed a cDNA-cloning
strategy whereby the conventional cloning by plaque hy-
bridization is substituted with a simple and quick fractiona-
tion of the cDNA library, followed by PCR-based detection.
This method is more reliable because PCR conditions can
be adjusted very stringently, avoiding any false positive sig-
nals, and it eliminates the need for any hybridization asso-
ciated with probe construction, labelling, and screening of
a complete cDNA library.
With this revised strategy we were able to successfully
identify and clone several ovine cDNAs that were differ-
entially expressed in one part of the hypophysis, the Pars
tuberalis.
Protocol
In these experiments, subtractive hybridization and enrich-
ment of subtracted cDNA by PCR were carried out accord-
ing to the manufacturer‘s instructions PCR-SelectTM cDNA
Subtraction Kit; (Clontech). Novel, differentially expressed
genes were separated as short PCR fragments on a native 8%
polyacrylamide gel, showing more than 60 discrete bands.
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All DNA bands were cut out of the gel, eluted (Ref. 3), ampli-
fied again by PCR and cloned into the vector pCR-ScriptTM
SK Amp (Stratagene). Transformants were controlled by
PCR. Bacterial colonies were transferred with a sterile tooth-
pick into the PCR cups (50 pmoles gene-specific primers,
25 µl PCR-Super-Mix (Life Technologies) and PCR was per-
formed as follows: 95◦C for 30 seconds, 63◦C for 30 sec-
onds, 72◦C for 1 minute [35 cycles]; 72◦C for 5 min) using
T3- (-ATT AAC CCT CAC TAA AGG GA-) and T7-primers
(-TAA TAC GAC TCA CTA TAG GG-) resulting in 58 dif-
ferent clones. DNA sequencing and analysis of 39 clones
revealed 18 novel genes (46%) and 21 genes that had al-
ready been cloned (54%; e.g., 2× tachykinin B, osteonectin,
synexin, CREM, DNA-binding proteins, 2 × IgG, comple-
ment component, endothelin receptor). With the excep-
tion of blood-specific genes, all others were tested for tissue-
specific expression by PCR (50 pmoles gene-specific DNA
primers deduced from the DNA sequences; 0.1 µg tissue-
specific cDNA as template; 20 µl PCR-Super-Mix (Life Tech-
nologies) in a total volume of 25 µl) showing remarkably
intense signals in the tested tissue for six of the novel and
five of the currently known genes.
For cloning we chose the novel differentially expressed
genes. The whole cloning procedure was carried out in five
days (Fig. 1). On the first day ten times 1.2 × 105 plaque-
forming units of a Pars tuberalis-specific cDNA library
(1.2 × 108 phages/ml; λZAP-ExpressTM (Stratagene) were
plated on 150 mm NZCYM-agar plates (Ref. 4). On the
second day the phages were isolated from the top-agar
by overlaying the plates with 7 ml SM-buffer. After gentle
agitation of the plates for ∼4 h the SM-buffer was trans-
ferred into sterile tubes, centrifuged, supplemented with
10% chloroform and stored at 4◦C. Each fraction (n =
10) was tested for the existence of cDNA clones by PCR
(see step a in Fig. 1; 1 µl lysat, 50 pmoles gene-specific
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FIGURE 1. Scheme of the cloning procedure. 1.2 × 106 recombinant phages of a hypothalamus/Pars tuberalis-specific cDNA library were fractionated
by two successive rounds of plating on agar plates, producing 1.5 × 104 individual phages/fraction. Each fraction was tested by PCR using specific primers
(a, b). 1.5 × 104 phages were again plated out and cut into 427 agar pieces, containing ∼40 plaques each. After transferring to 0.5 ml SM buffer, 10%
chloroform lysates of 12 aliquots each were pooled to 35 pools, which were again combined, to give five ‘master pools’. These were analysed by three
rounds of PCR (c−e). From a positive lysate, 100−200 plaques/plate were plated out. Single plaques were isolated with Pasteur pipettes and transferred
to SM buffer and10% chloroform, cobined to give ten pools and analysed by PCR (f, g).
primers, 24 µl PCR-Super-Mix (Life Technologies). Because
the lysates contained 10 mmoles/l Mg2+ ions, the addition
of 1 µl lysate in a total volume of 25 µl increased the Mg2+
concentration from 1.6 mmoles/l to 2.0 mmoles/l. There-
fore, control experiments were carried out with each pair
of primers to varify the maximal content of Mg2+ ions in
the PCR reactions. Positive signals could be detected for
every tested cDNA clone. This step was repeated by plat-
ing ten times 1.5 × 104 phages/plate of a positive fraction
(see step b in Fig. 1). 1.5 × 104 phages of the lysate in
which the cDNAs have been detected were plated on 150
mm NZCYM-agar plates. On the fourth day each agar disk
was cut into small agar blocks (n = 427), each containing
∼40 independent phage plaques. The agar blocks were put
into 0.5 ml SM buffer, 10% chloroform. Block lysates were
pooled consecutively to 35 pools that were again combined
to 5 ‘master-pools’, which were analyzed by three rounds of
PCR (see steps c−e in Fig. 1; 1 µl pooled lysate, 50 pmoles
gene-specific primers, 24 µl PCR-Super-Mix (Life Technolo-
gies). This resulted in one positive agar block lysate that
was again plated to 100−200 plaques/plate. On the fifth
day, 100 plaques were transferred to 0.5 ml SM buffer,
10% chloroform with sterile Pasteur pipettes and combined
to 10 pools per 10 single plaques. After detecting posi-
tive single phages by PCR (see steps f, g in Fig. 1), cDNA
clones were excised in vivo from the λZAP-ExpressTM vector
(Stratagene) and the cDNA was inserted in the phagemid
vector pBK-CMV (Stratagene) and analyzed by restriction
mapping.
In conclusion, the cloning technique described here
provides a powerful, quick and money-saving method
for isolating a few different clones, replacing hybridiza-
tion experiments by PCR techniques. Furthermore, sev-
eral cDNA clones can be handled in parallel by us-
ing the same fractionated lysates and pools of agar
blocks.
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Products Used
cDNA: cDNA from Clontech Inc
pCR-Script: pCR-Script from Stratagene
PCR SuperMix: PCR SuperMix from Life Technolo-
gies (Gibco BRL)
PCR SuperMix: PCR SuperMix from Life Technolo-
gies (Gibco BRL)
ZAP-Express: ZAP-Express from Stratagene
PCR SuperMix: PCR SuperMix from Life Technolo-
gies (Gibco BRL)
PCR SuperMix: PCR SuperMix from Life Technolo-
gies (Gibco BRL)
ZAP-Express: ZAP-Express from Stratagene
pBK-CMV: pBK-CMV from Stratagene
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